The effect of phytosomal curcumin on fatty liver

Not Applicable

• Conditions: on-alcoholic fatty liver.; Fatty (change of) liver, not elsewhere classified; K76.0

• Registration Number: IRCT20121216011763N39
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Willingness to participate in the study
age 18-65 years
Non-alcoholic fatty liver (Grade 1-3) diagnosed by previous ultrasound

Exclusion Criteria

Pregnancy and lactation
Alcoholic fatty liver disease
Tobacco consumption
Heart, Lung and Kidney Diseases, Hepatitis, Cirrhosis, Biliary and Immune Disorders, Diabetes, Cushing's Syndrome
Intake of lipid and glucose lowering drugs, Vitamin E and D, orthoedoxic acid, phenytoin, tamoxifen, lithium, corticosteroids and methotrexate
Weight loss and bariatric surgery in the last year

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Aspartate amino transferase. Timepoint: Before intervention, end of intervention. Method of measurement: Enzymatic photometric.;Degree of liver fibrosis. Timepoint: Before intervention, end of intervention. Method of measurement: Fibroscan device.;Degree of liver steatosis. Timepoint: Before intervention, end of intervention. Method of measurement: Fibroscan device.;Alkaline amino transferase. Timepoint: Before intervention, end of intervention. Method of measurement: Enzymatic photometric.

Secondary Outcome Measures

Name	Time	Method
TG. Timepoint: Before intervention, end of intervention. Method of measurement: Enzymatic.;Tch. Timepoint: Before intervention, end of intervention. Method of measurement: Enzymatic.;HDL. Timepoint: Before intervention, end of intervention. Method of measurement: Enzymatic.;LDL. Timepoint: Before intervention, end of intervention. Method of measurement: Fried Wald Equation equation.;FBS. Timepoint: Before intervention, end of intervention. Method of measurement: Enzymatic.;Weight. Timepoint: Before intervention, end of intervention. Method of measurement: Digital scale.;Waist. Timepoint: Before intervention, end of intervention. Method of measurement: Meters irreversible.;BMI. Timepoint: Before intervention, end of intervention. Method of measurement: Body Mass Index Formula.